Related Experiment Video

Updated: Jul 22, 2026

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
11:28

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

Published on: March 13, 2015

Serologic diagnosis of viral hepatitis

M H Sjogren1

  • 1Walter Reed Army Medical Center, Washington, DC.

Gastroenterology Clinics of North America
|September 1, 1994
PubMed

Abstract:

The diagnosis of viral hepatitis is complex, particularly when the five leading causative agents belong to different virus families and evoke distinct immunologic response. This article connects known serologic markers to new methods and guides the ordering and interpretation of contemporary laboratory tests.

More Related Videos

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
04:11

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

Hepatitis E Virus Fluorescence Reduction Neutralization Test for Measuring Neutralizing Antibody Titers
07:58

Hepatitis E Virus Fluorescence Reduction Neutralization Test for Measuring Neutralizing Antibody Titers

Published on: May 22, 2026

Related Experiment Videos

Last Updated: Jul 22, 2026

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
11:28

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

Published on: March 13, 2015

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
04:11

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

Hepatitis E Virus Fluorescence Reduction Neutralization Test for Measuring Neutralizing Antibody Titers
07:58

Hepatitis E Virus Fluorescence Reduction Neutralization Test for Measuring Neutralizing Antibody Titers

Published on: May 22, 2026

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...

Articles linked to this work by shared authors, journal, and citation graph.

Hepatitis C in Peru: risk factors for infection, potential iatrogenic transmission, and genotype distribution.

The American journal of tropical medicine and hygiene·2001

Hepatic decompensation associated with lamivudine: a case report and review of lamivudine-induced hepatotoxicity.

The American journal of gastroenterology·2001

Hepatitis B virus DNA in persons with isolated antibody to hepatitis B core antigen who subsequently received hepatitis B vaccine.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·1998

Serologic diagnosis of viral hepatitis.

The Medical clinics of North America·1996

Evaluation of liver histology, ALT elevation, and HCV RNA titer in patients with chronic hepatitis C.

The American journal of gastroenterology·1996

Administration of hepatitis A vaccine to a military population by needle and jet injector and with hepatitis B vaccine.

The Journal of infectious diseases·1995

Food and Drug Administration-Approved Fecal Microbiota-Based Therapies for Recurrent Clostridioides difficile Infection.

Gastroenterology clinics of North America·2026

Non-Fecal Microbiota Transplantation Strategies for Treatment of Recurrent Clostridioides difficile Infection.

Gastroenterology clinics of North America·2026

Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.

Gastroenterology clinics of North America·2026

Management of Clostridioides difficile Infection in Patients with Inflammatory Bowel Disease.

Gastroenterology clinics of North America·2026

Treatment of Severe and Fulminant Clostridioides difficile Infections.

Gastroenterology clinics of North America·2026

Non-Severe Clostridium difficile Infection.

Gastroenterology clinics of North America·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us